$ESNT

WEINSTOCK DAVID B sold $349K of ESNT

WEINSTOCK DAVID B (SVP and CFO) sold 5,500 shares of Essent Group Ltd. (ESNT) at $63.51 ($0.35M total) on 2026-06-26 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · WEINSTOCK DAVID B
Published Jun 30, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 30, 2026, 8:58 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ESNT
Neutral
high confidence
Mentioned
$ESNT
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ESNTNeutralLow
01

Why it matters

The disclosure updates the insider’s post-transaction holdings (35,494 shares) and confirms the sale was pre-arranged under Rule 10b5-1.

02

Market read

Traders may treat this as incremental sentiment data, but the 10b5-1 framing generally limits tradable fundamental implications.

03

What to watch

The article provides only the sale details; it does not include any concurrent insider purchases, guidance changes, or operational news that would strengthen a directional thesis.

Relevance 3/10Novelty 5/10Timing: Filed 2026-06-30 after-hours; reflects sale executed 2026-06-26.

Background

SEC Form 4 reports an insider transaction by Essent Group’s SVP and CFO, David B. Weinstock.

Company-level read

Ticker impact

$ESNTNeutralHigh confidence
Context

Essent Group CFO sold 5,500 shares in an open-market transaction at $63.51 on 2026-06-26 under a pre-arranged 10b5-1 plan.

Expected impact

Low near-term impact; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a Form 4 insider sale with disclosed pricing/size, but it is explicitly under a pre-arranged 10b5-1 plan, which typically reduces interpretive weight.

Market effects

No sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can still coincide with internal caution; traders may watch for follow-on sales or changes in buying behavior.

Key entities

  • Essent Group Ltd.

    Subject of the Form 4 insider transaction; CFO sold shares under a pre-arranged 10b5-1 plan.

  • David B. Weinstock

    SVP and CFO who executed the open-market sale of 5,500 shares.

Related articles

$ESNTMedAI 8/10

Essent Group profit rises 7% as new P&C segment grows

Essent Group reported 2Q net income of $189.7 million, or $2.08 per diluted share, up from $177 million, or $1.93, a year earlier. Profit rose as its P&C reinsurance expansion increased premiums. P&C net premiums were $249 million for 1H 2026, and net premiums earned rose to $73 million. Essent expects $320 million written P&C premium in 2026 and declared a 35-cent quarterly dividend.

$ESNTMedAI 8/10

Essent Group (NYSE:ESNT) Delivers Strong Q2 CY2026 Numbers

Essent Group (NYSE:ESNT) reported Q2 2026 revenue of $362.7 million, up 13.6% year on year, beating Wall Street estimates by 9.7%. GAAP profit was $2.08 per share, 19.3% above consensus. The article also cites book value per share growth of about 11.7% over five years and notes the stock rose 2.4% to $67.08 after results.

$ESNTMed

Unilever, Barclays & Shell: Markets live

Unilever (ULVR) shares rose after it upgraded full-year outlook on improving sales. It reported €25.6bn revenue and €4.66bn pre-tax profit for six months to 30 June, with underlying sales up 4.8%. Other FTSE movers included Barclays (BARC) guidance and buyback, Forterra (FORT) results, and Canal+ (CAN) profit jump tied to MultiChoice consolidation.